Migraine and Migraine Management: A Review

  • Nagavamsidhar Muthyala Pratishta Institute of Pharmaceutical Sciences
  • ZL Qadrie Pratishta Institute of Pharmaceutical Sciences,
  • A Suman Pratishta Institute of Pharmaceutical Sciences,
Keywords: Migraine, FHM, GON, SSRI, CBT

Abstract

Pain is defined as an unpleasant sensory and emotional experience associated with actual or potential tissue damage or described in terms of such damage. The WHO has rated migraine amongst the top 20 most disabling life time conditions. Migraine is a pervasive and debilitating, chronic neurological painful disorder, affecting from 15% to 29% of the general population. It is the second most common cause of headache characterized by recurrent episodes of headache and associated symptoms i.e. nausea, sensitivity to light and noise that typically last from 4 to 72 hours which is divided into four phases. Migraine is well explained with three hypothesis i.e., vascular, platelet, central nervous system. It affects people of all groups, sexes, races and social classes around the globe. Migraine can occur due to various trigger factors and can be managed with both pharmacological and non-pharmacological treatment.

Author Biographies

Nagavamsidhar Muthyala, Pratishta Institute of Pharmaceutical Sciences

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Suryapet, Hyderabad, Telangana, India

ZL Qadrie, Pratishta Institute of Pharmaceutical Sciences,

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Suryapet, Hyderabad, Telangana, India

A Suman, Pratishta Institute of Pharmaceutical Sciences,

Department of Pharmacy Practice,
Pratishta Institute of Pharmaceutical Sciences,
Suryapet, Hyderabad, Telangana, India

Published
2018-04-01
How to Cite
[1]
Muthyala, N., Qadrie, Z. and Suman, A. 2018. Migraine and Migraine Management: A Review. PharmaTutor. 6, 4 (Apr. 2018), 8-17. DOI:https://doi.org/10.29161/PT.v6.i4.2018.8.
Section
Articles